Michael T Liu

Title: Michael T Liu: Innovator in Monoclonal Antibodies

Introduction

Michael T Liu is a prominent inventor based in Irvine, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, Liu's work has the potential to impact various medical applications.

Latest Patents

One of Liu's latest patents focuses on IP-10 antibodies and their uses. This invention provides isolated monoclonal antibodies, particularly human antibodies, that bind to IP-10 with high affinity. These antibodies inhibit the binding of IP-10 to its receptor, as well as block IP-10-induced calcium flux and cell migration. The patent also includes nucleic acid molecules encoding the antibodies, expression vectors, host cells, and methods for expressing these antibodies. Additionally, it covers immunoconjugates, bispecific molecules, and pharmaceutical compositions that incorporate the antibodies. The invention outlines methods for inhibiting IP-10 activity, which could be beneficial in treating various inflammatory and autoimmune diseases.

Career Highlights

Throughout his career, Michael T Liu has worked with notable companies such as Medarex Inc. and Bristol-Myers Squibb Company. His experience in these organizations has contributed to his expertise in the field of antibody development and therapeutic applications.

Collaborations

Liu has collaborated with several professionals in his field, including Shrikant Deshpande and Haichun Huang. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Michael T Liu is a distinguished inventor whose work in monoclonal antibodies has the potential to advance medical treatments for inflammatory and autoimmune diseases. His contributions to the field are noteworthy and reflect his commitment to innovation in biotechnology.